Hereditary spastic paraplegia: clinical genetic study of 15 families.

BACKGROUND Autosomal dominant hereditary spastic paraplegia (ADHSP) is mainly caused by mutations in the SPG4 gene, which encodes a new member of the AAA (adenosine triphosphatases associated with diverse cellular activities) protein family (spastin). Accumulation of genotype-phenotype correlation is important for better understanding of SPG4-linked hereditary spastic paraplegia. OBJECTIVES To perform a clinical and genetic study of families with ADHSP and to perform the functional analysis of the founder mutation discovered in the SPG4 gene. DESIGN Genetic and clinical study. Patients Fifteen unrelated families with ADHSP originating from southern Scotland. MAIN OUTCOME MEASURES Clinical assessment, linkage analysis, haplotype study, expression of mutant spastin protein in cultured cells. RESULTS Nine families with ADHSP were linked to the SPG4 locus at 2p21-p24. Sequence analysis of SPG4showed a novel N386S mutation in all 9 of these families. Expression of mutant spastin showed aberrant distribution in cultured cells. Haplotype analysis suggested the existence of a common founder. Clinical examination of the affected members carrying the mutation showed phenotypic variations including broad range of age at onset and disease duration and additional neurologic features such as mental retardation. Magnetic resonance imaging demonstrated unique features, including thin corpus callosum and atrophy of the cerebellum in 2 patients. Linkage and sequence analyses showed no evidence of linkage to the currently known ADHSP loci in the remaining 6 families. CONCLUSIONS A founder SPG4 mutation N386S was identified in the families with ADHSP originating from southern Scotland. Clinical investigation showed intrafamilial and interfamilial phenotypic variations. The genetic study demonstrated evidence of further genetic heterogeneity in ADHSP.

[1]  E. Reid,et al.  Science in motion: common molecular pathological themes emerge in the hereditary spastic paraplegias , 2003, Journal of medical genetics.

[2]  A. Paterson,et al.  Clinical and genetic study of a large Italian family linked to SPG12 locus , 2002, Neurology.

[3]  M. Pericak-Vance,et al.  A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). , 2002, American journal of human genetics.

[4]  H. Tachibana,et al.  Hereditary spastic paraplegia with thin corpus callosum and cataract: a clinical description of two siblings , 2002, Acta neurologica Scandinavica.

[5]  A. Dürr,et al.  Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. , 2002, American journal of human genetics.

[6]  E. Rugarli,et al.  Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics. , 2002, Human molecular genetics.

[7]  P. Hedera,et al.  Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia , 2001, Nature Genetics.

[8]  R. Ravazzolo,et al.  A refined physical and transcriptional map of the SPG9 locus on 10q23.3–q24.2 , 2000, European Journal of Human Genetics.

[9]  H. Utsumi,et al.  Linkage of autosomal recessive hereditary spastic paraplegia with mental impairment and thin corpus callosum to chromosome 15q13–15 , 2000, Annals of neurology.

[10]  Bertrand Fontaine,et al.  Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia , 1999, Nature Genetics.

[11]  M. Devoto,et al.  Genetic mapping to 10q23.3-q24.2, in a large Italian pedigree, of a new syndrome showing bilateral cataracts, gastroesophageal reflux, and spastic paraparesis with amyotrophy. , 1999, American journal of human genetics.

[12]  Sergio Cocozza,et al.  Spastic Paraplegia and OXPHOS Impairment Caused by Mutations in Paraplegin, a Nuclear-Encoded Mitochondrial Metalloprotease , 1998, Cell.

[13]  J. Melki,et al.  Mutations of SPG4 are responsible for a loss of function of spastin, an abundant neuronal protein localized in the nucleus. , 2003, Human molecular genetics.